Physician profile
Eric Carlson
NPI 1992384671
$256.21
in general payments reported to CMS, 2019-2025
8 companies · $73.27 in 2025
The $73.27 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $26.94 · 2024: $156 · 2025: $73.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $60.46 | 2024 | Aetos Shoulder System |
| Glaxosmithkline, LLC. | $45.22 | 2023-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.54 | 2024 | Jardiance |
| Alexion Pharmaceuticals, INC. | $31.13 | 2025 | Ultomiris |
| Lundbeck LLC | $24.12 | 2025 | Rexulti |
| Gilead Sciences, INC. | $24.03 | 2024 | |
| Sumitomo Pharma America, INC. | $18.02 | 2025 | Myfembree |
| Otsuka America Pharmaceutical, INC. | $17.69 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.